Meta-Analysis Of Brain And Central Nervous System Microarray Datasets

Icxa Khandelwal, Aditi Sharma, Jayashree Ramana


Brain and CNS cancer are rare in comparison to other types of cancer. Currently there are no effective therapies for their treatment. In this study, meta-analysis of microarray datasets of Brain and CNS cancer was done to obtain significantly upregulated genes with increased statistical power and generalizability.  A total of 130 significantly up-regulated genes were obtained. Some of the genes found during analysis have not yet been associated with this cancer. Different biological networks were created and analyzed using the significantly up-regulated genes as input. For each network, the most significant pathways have also been identified computationally. 


microarray, meta-analysis

Full Text:



Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta neuropathologica. 2016 Jun 1;131(6):803-20.

Ferlay J, Seorjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: Accessed May 30, 2016.

Miranda-Filho A, Piñeros M, Soerjomataram I, Deltour I, Bray F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro-oncology. 2016 Aug 29;19(2):270-80.

Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurologic clinics. 2007 Nov 30;25(4):867-90.

Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, Visser O. Changing incidence and improved survival of gliomas. European journal of cancer. 2014 Sep 30;50(13):2309-18.

Davis D, Hoel D, Percy C, Ahlbom A, Schwartz J. Is brain cancer mortality increasing in industrial countries?. Annals of the New York Academy of Sciences. 1990 Nov 1;609(1):191-204.

Grieg NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. JNCI: Journal of the National Cancer Institute. 1990 Oct 17;82(20):1621-4.

Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro-oncology. 2006 Jan 1;8(1):27-37.

Wigertz A, Lönn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, Johansen C, Klæboe L, Salminen T, Schoemaker MJ, Swerdlow AJ. Allergic conditions and brain tumor risk. American journal of epidemiology. 2007 Jul 23;166(8):941-50.

Cahoon EK, Inskip PD, Gridley G, Brenner AV. Immune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans. British journal of cancer. 2014 Apr 1;110(7):1825.

Miranda-Filho A, Piñeros M, Soerjomataram I, Deltour I, Bray F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro-oncology. 2016 Aug 29;19(2):270-80.

Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pander A, Chinnaiyan AM. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004 Jan 1;6(1):1-6.

Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007 Feb 1;9(2):166-80.

Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences. 2001 Apr 24;98(9):5116-21.

Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003 Feb;34(2):374.

Goonesekere NC, Wang X, Ludwig L, Guda C. A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers. PloS one. 2014 Apr 16;9(4):e93046.

Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, Chory J. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics. 2006 Sep 18;22(22):2825-7.

Laing E, Smith CP. RankProdIt: A web-interactive Rank Products analysis tool. BMC research notes. 2010 Aug 6;3(1):221.

Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS letters. 2004 Aug 27;573(1-3):83-92.

Dudley JT, Tibshirani R, Deshpande T, Butte AJ. Disease signatures are robust across tissues and experiments. Molecular systems biology. 2009 Jan 1;5(1):307.

Ni W, Luo L, Ping Z, Yuan HP, Zhao XD, Xu W. Prognostic value of ALDH1A3 promoter methylation in gliob; astoma: a single center experience in Western China. Asian Pacific Journal of Cancer Prevention. 2015;16(2):591-4.

Han J, Yang L, Puri RK. Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells. Journal of neuro-oncology. 2005 Mar 1;72(1):35-46.

Barnum SR, Jones JL, Benveniste EN. Interleukin‐1 and tumor necrosis factor‐mediated regulation of C3 gene expression in human astroglioma cells. Glia. 1993 Mar 1;7(3):225-36.

Onishi M, Ichikawa T, Kurozumi K, Inoue S, Maruo T, Otani Y, Fujii K, Ishida J, Shimazu Y, Yoshida K, Michiue H. Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma. Brain tumor pathology. 2015 Jul 1;32(3):184-94.

Barnum SR, Jones JL, Benveniste EN. Interleukin‐1 and tumor necrosis factor‐mediated regulation of C3 gene expression in human astroglioma cells. Glia. 1993 Mar 1;7(3):225-36.

Saidi A, Javerzat S, Bellahcene A, De Vos J, Bello L, Castronovo V, Deprez M, Loiseau H, Bikfalvi A, Hagedorn M. Experimental anti‐angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. International journal of cancer. 2008 May 15;122(10):2187-98.

Kleinschmidt‐DeMasters BK, Donson AM, Vogel H, Foreman NK. Pilomyxoid astrocytoma (PMA) shows significant differences in gene expression vs. pilocytic astrocytoma (PA) and variable tendency toward maturation to PA. Brain Pathology. 2015 Jul 1;25(4):429-40.

Liu Y, Carson-Walter EB, Cooper A, Winans BN, Johnson MD, Walter KA. Vascular gene expression patterns are conserved in primary and metastatic brain tumors. Journal of neuro-oncology. 2010 Aug 1;99(1):13-24.

Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clinical Cancer Research. 2004 Mar 15;10(6):2072-81.

Li M, Mukasa A, Inda MD, Zhang J, Chin L, Cavenee W, Furnari F. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma. Journal of Experimental Medicine. 2011 Dec 19;208(13):2657-73.

Kiviniemi A, Gardberg M, Frantzén J, Parkkola R, Vuorinen V, Pesola M, Minn H. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival. Journal of neuro-oncology. 2015 Sep 1;124(2):237-45.

Wang L, Wei B, Hu G, Wang L, Bi M, Sun Z, Jin Y. Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray. Molecular medicine reports. 2015 Aug 1;12(2):1991-6.

Pen A, Moreno MJ, Martin J, Stanimirovic DB. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: Microarray study of laser‐captured glioblastoma vessels. Glia. 2007 Apr 15;55(6):559-72.

Jones TA, Jeyapalan JN, Forshew T, Tatevossian RG, Lawson AR, Patel SN, Doctor GT, Mumin MA, Picker SR, Phipps KP, Michalski A. Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways. Acta neuropathologica communications. 2015 Dec 18;3(1):86.

Marie SK, Okamoto OK, Uno M, Hasegawa AP, Oba‐Shinjo SM, Cohen T, Camargo AA, Kosoy A, Carlotti CG, Toledo S, Moreira‐Filho CA. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. International journal of cancer. 2008 Feb 15;122(4):807-15.

Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, Brogi E, Brastianos PK, Hahn WC, Holsinger LJ, Massagué J. Analysis of tumor-and stroma-supplied proteolytic networks reveals a brain metastasis-promoting role for cathepsin S. Nature cell biology. 2014 Sep;16(9):876.

Carén H, Djos A, Nethander M, Sjöberg RM, Kogner P, Enström C, Nilsson S, Martinsson T. Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma. BMC cancer. 2011 Feb 11;11(1):66.

Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research. 2008 Nov 25;37(1):1-3.

Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic acids research. 2010 Jun 21;38(suppl_2):W214-20.

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research. 2003 Nov 1;13(11):2498-504.